M&A Corner
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems12 Feb 2024
Bruker Corporation (Nasdaq: BRKR) has acquired Spectral Instruments Imaging LLC, enhancing its Bruker BioSpin Preclinical Imaging (PCI) division’s offerings in... Continue Reading
|
Inovalon Acquires VigiLanz, Expanding Reach in Clinical Surveillance and Patient Safety12 Feb 2024
Inovalon, a provider of cloud-based healthcare data analytics solutions, announced today the acquisition of VigiLanz, a prominent provider of SaaS-based... Continue Reading
|
Novo Holdings Buys CDMO Catalent for $16.5B to Boost Semaglutide Supply12 Feb 2024
Catalent, a contract development and manufacturing organization, is set to merge with Novo Holdings for $16.5 billion in an all-cash... Continue Reading
|
Merck Animal Health to Acquire Elanco’s Aqua Business12 Feb 2024
Merck Animal Health, a division of Merck & Co., Inc., plans to acquire Elanco Animal Health’s aqua business for $1.3... Continue Reading
|
MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value12 Feb 2024
MorphoSys AG announced a Business Combination Agreement with Novartis, offering €68.00 per share in cash to acquire all outstanding shares.... Continue Reading
|
Fabric Acquires Conversational AI Care Assistant GYANT06 Feb 2024
Healthcare experience optimization leader Fabric has acquired GYANT, a conversational AI care assistant and patient engagement suite provider, to strengthen... Continue Reading
|
AVROBIO and Tectonic Therapeutic Announce Merger06 Feb 2024
AVROBIO is set to acquire Tectonic Therapeutic in an all-stock transaction, with the combined entity operating as Tectonic Therapeutic, Inc.... Continue Reading
|
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals06 Feb 2024
Concentra Biosciences has completed its acquisition by eMed in a cash tender offer valued at approximately $38 million. Under the... Continue Reading
|
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating EnrollmentScience 37 Stockholders to Receive $5.75 per share in Cash.06 Feb 2024
Clinical research leader Science 37 is set to be acquired by eMed, a virtual care and treatment provider, in a... Continue Reading
|
Carmot Therapeutics Announces Completion of Acquisition by Roche06 Feb 2024
Roche Group has completed its acquisition of Carmot Therapeutics, a biotechnology company specializing in metabolic diseases like obesity and diabetes.... Continue Reading
|